A R Tyrka1, D E Burgers, N S Philip, L H Price, L L Carpenter. 1. Mood Disorders Research Program and Laboratory for Clinical and Translational Neuroscience, Butler Hospital, Providence, RI, USA; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
Abstract
OBJECTIVE: This article provides an overview of research on the neurobiological correlates of childhood adversity and a selective review of treatment implications. METHOD: Findings from a broad array of human and animal studies of early adversity were reviewed. RESULTS: Topics reviewed include neuroendocrine, neurotrophic, neuroimaging, and cognitive effects of adversity, as well as genetic and epigenetic influences. Effects of early-life stress on treatment outcome are considered, and development of treatments designed to address the neurobiological abnormalities is discussed. CONCLUSION: Early adversity is associated with abnormalities of several neurobiological systems that are implicated in the development of psychopathology and other medical conditions. Early-life stress negatively impacts treatment outcome, and individuals may require treatments that are specific to this condition.
OBJECTIVE: This article provides an overview of research on the neurobiological correlates of childhood adversity and a selective review of treatment implications. METHOD: Findings from a broad array of human and animal studies of early adversity were reviewed. RESULTS: Topics reviewed include neuroendocrine, neurotrophic, neuroimaging, and cognitive effects of adversity, as well as genetic and epigenetic influences. Effects of early-life stress on treatment outcome are considered, and development of treatments designed to address the neurobiological abnormalities is discussed. CONCLUSION: Early adversity is associated with abnormalities of several neurobiological systems that are implicated in the development of psychopathology and other medical conditions. Early-life stress negatively impacts treatment outcome, and individuals may require treatments that are specific to this condition.
Authors: Ilya M Veer; Nicole Y L Oei; Philip Spinhoven; Mark A van Buchem; Bernet M Elzinga; Serge A R B Rombouts Journal: Psychoneuroendocrinology Date: 2011-12-26 Impact factor: 4.905
Authors: Audrey R Tyrka; Lawrence H Price; Joel Gelernter; Caroline Schepker; George M Anderson; Linda L Carpenter Journal: Biol Psychiatry Date: 2009-07-12 Impact factor: 13.382
Authors: Charles L Raison; Robin E Rutherford; Bobbi J Woolwine; Chen Shuo; Pamela Schettler; Daniel F Drake; Ebrahim Haroon; Andrew H Miller Journal: JAMA Psychiatry Date: 2013-01 Impact factor: 21.596
Authors: Michael T Treadway; Merida M Grant; Zhaohua Ding; Steven D Hollon; John C Gore; Richard C Shelton Journal: PLoS One Date: 2009-03-26 Impact factor: 3.240
Authors: Audrey R Tyrka; Stephanie H Parade; Nicole M Eslinger; Carmen J Marsit; Corina Lesseur; David A Armstrong; Noah S Philip; Brittney Josefson; Ronald Seifer Journal: Dev Psychopathol Date: 2015-05
Authors: Uraina S Clark; Lawrence H Sweet; Susan Morgello; Noah S Philip; Ronald A Cohen Journal: Brain Imaging Behav Date: 2017-06 Impact factor: 3.978
Authors: Alberto Rodríguez-Quiroga; Karina S MacDowell; Juan C Leza; José Luis Carrasco; Marina Díaz-Marsá Journal: Eat Weight Disord Date: 2020-05-18 Impact factor: 4.652
Authors: Justin Parent; Stephanie H Parade; Laura E Laumann; Kathryn K Ridout; Bao-Zhu Yang; Carmen J Marsit; Ronald Seifer; Audrey R Tyrka Journal: Dev Psychopathol Date: 2017-12